Tango Therapeutics Inc.（股票代码：TNGX）今日盘中股价大幅下挫10.82%，引起了市场的广泛关注。
消息面上，根据路透社报道，华尔街知名投行杰富瑞（Jefferies）将该公司的股票评级从“买入”下调至“持有”。尽管杰富瑞同时将目标价从18美元上调至27美元，但评级的下调通常被市场解读为分析师对公司短期前景转为谨慎，这可能是引发股价盘中大幅下跌的主要原因。
市场对主要投行的评级变动反应敏感，尤其是在交易时段内。此次杰富瑞的评级调整反映了其对Tango Therapeutics的最新看法，并直接影响了投资者的短期交易决策，导致抛压加剧。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.